What is the address of Dr. Marjan Verbruggen?

The registered office of Dr. Marjan Verbruggen is located at Menegemlei 31, 2100 Antwerpen.

Is Dr. Marjan Verbruggen still active?

Yes. According to the CBE (16 September 2026) Dr. Marjan Verbruggen is active, legal situation “Normale toestand”, started on 5 December 2016.

Is Dr. Marjan Verbruggen registered on Peppol?

Yes, Dr. Marjan Verbruggen is registered on the Peppol network with ID 0208:0666945571.

What is the enterprise number of Dr. Marjan Verbruggen?

The enterprise number of Dr. Marjan Verbruggen is BE0666945571.

When was Dr. Marjan Verbruggen founded?

Dr. Marjan Verbruggen was founded on 5 December 2016.

Who are the directors of Dr. Marjan Verbruggen?

According to the 2025 annual accounts, the directors of Dr. Marjan Verbruggen are: Marjan Verbruggen.

Is Dr. Marjan Verbruggen a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 December 2016; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Marjan Verbruggen make in 2025?

Dr. Marjan Verbruggen posted a profit after taxes of € 181,452 in financial year 2025.

What is the revenue of Dr. Marjan Verbruggen?

As a small company, Dr. Marjan Verbruggen is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 234,187.

Dr. Marjan Verbruggen (Private Limited) - Antwerpen

Dossier Dr. Marjan Verbruggen, printed on 16 September 2026 from databakkes.be/en/0666945571/dr-marjan-verbruggen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Marjan Verbruggen from Antwerpen, company number BE0666945571, closed financial year 2025 with a result of € 181,452 after tax. For that financial year Dr. Marjan Verbruggen recorded a gross margin of € 234,187 and equity of € 273,017. Compared with financial year 2024, the result moved from € 307,697 to € 181,452. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.

What it is worth Healthy

€ 273,017

▼ 42% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 181,452

▼ 41% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 73,546

▼ 38% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 377,059 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,931

▲ € 2,771 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 420,203 Gross margin 2022: € 420,203 First fiscal year in the series	€ 274,009 Gross margin 2023: € 274,009 ▼ 35% vs 2022 (€ 420,203) Unfavourable step	€ 404,342 Gross margin 2024: € 404,342 ▲ 48% vs 2023 (€ 274,009) Favourable step	€ 234,187 Gross margin 2025: € 234,187 ▼ 42% vs 2024 (€ 404,342) Unfavourable step	▼ 42%
Profit after taxes	€ 316,125 Profit after taxes 2022: € 316,125 First fiscal year in the series	€ 208,589 Profit after taxes 2023: € 208,589 ▼ 34% vs 2022 (€ 316,125) Unfavourable step	€ 307,697 Profit after taxes 2024: € 307,697 ▲ 48% vs 2023 (€ 208,589) Favourable step	€ 181,452 Profit after taxes 2025: € 181,452 ▼ 41% vs 2024 (€ 307,697) Unfavourable step	▼ 41%
Equity	€ 475,868 Equity 2022: € 475,868 First fiscal year in the series	€ 472,692 Equity 2023: € 472,692 ▼ 1% vs 2022 (€ 475,868) Unfavourable step	€ 468,624 Equity 2024: € 468,624 ▼ 1% vs 2023 (€ 472,692) Unfavourable step	€ 273,017 Equity 2025: € 273,017 ▼ 42% vs 2024 (€ 468,624) Unfavourable step	▼ 42%
Total debts	€ 16,264 Total debts 2022: € 16,264 First fiscal year in the series	€ 16,264 Total debts 2023: € 16,264 Unchanged (€ 16,264) Unfavourable step	€ 160 Total debts 2024: € 160 ▼ 99% vs 2023 (€ 16,264) Favourable step	€ 2,931 Total debts 2025: € 2,931 ▲ € 2,771 vs 2024 (€ 160) Unfavourable step	▲ € 2,771
Cash	€ 150,241 Cash 2022: € 150,241 First fiscal year in the series	€ 249,711 Cash 2023: € 249,711 ▲ 66% vs 2022 (€ 150,241) Favourable step	€ 118,493 Cash 2024: € 118,493 ▼ 53% vs 2023 (€ 249,711) Unfavourable step	€ 73,546 Cash 2025: € 73,546 ▼ 38% vs 2024 (€ 118,493) Unfavourable step	▼ 38%
Retained profit	€ 457,268 Retained profit 2022: € 457,268 First fiscal year in the series	€ 454,092 Retained profit 2023: € 454,092 ▼ 1% vs 2022 (€ 457,268) Unfavourable step	€ 450,024 Retained profit 2024: € 450,024 ▼ 1% vs 2023 (€ 454,092) Unfavourable step	€ 254,417 Retained profit 2025: € 254,417 ▼ 43% vs 2024 (€ 450,024) Unfavourable step	▼ 43%
Dividend	€ 405,882 Dividend 2022: € 405,882 First fiscal year in the series	€ 211,765 Dividend 2023: € 211,765 ▼ 48% vs 2022 (€ 405,882) Unchanged	€ 311,765 Dividend 2024: € 311,765 ▲ 47% vs 2023 (€ 211,765) Unchanged	€ 377,059 Dividend 2025: € 377,059 ▲ 21% vs 2024 (€ 311,765) Unchanged	▲ 21%
Balance sheet total	€ 492,131 Balance sheet total 2022: € 492,131 First fiscal year in the series	€ 488,956 Balance sheet total 2023: € 488,956 ▼ 1% vs 2022 (€ 492,131) Unchanged	€ 468,784 Balance sheet total 2024: € 468,784 ▼ 4% vs 2023 (€ 488,956) Unchanged	€ 275,948 Balance sheet total 2025: € 275,948 ▼ 41% vs 2024 (€ 468,784) Unchanged	▼ 41%

Key figures of Dr. Marjan Verbruggen, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Marjan Verbruggen?

What happened at Dr. Marjan Verbruggen in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 28, 2026 New annual accounts for financial year 2025: profit of € 181,452 (▼ 41% vs 2024). filed late Source: NBB ↗
Dec 5, 2016 New establishment in Antwerpen. KBO
Dec 5, 2016 Start of the company according to the CBE. KBO

In short

From € 316,125 profit in 2022 to € 181,452 profit in 2025.

Paid € 321,572 in corporate taxes since 2022.

Best year ever: 2022, with € 316,125 profit.

Paid out € 1.3 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Marjan Verbruggen? We notify you, reason included.

Follow Dr. Marjan Verbruggen

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit